Rank 12 • Biotech & Discovery
Schrodinger
Provides a physics-based computational platform for molecular modeling to accelerate material and drug discovery.
Visit website- Signal Score
- 92.9
- Total raised
- $450M
- Stage
- Public
- Founded
- 1990
- Headquarters
- New York, USA
- Region
- North America
Their signal
Schrodinger is the foundational software provider for computational chemistry. Its hybrid business model combines enterprise software licensing with a robust internal pipeline of collaborative drug discovery programs.
Signal Score 92.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.